Can Gene Therapy for Sickle Cell Disease Be Cost-Effective?

(MedPage Today) -- Gene therapy may not be cost-effective in treating patients with sickle cell disease (SCD) via conventional cost-effectiveness analysis standards, but it can be an equitable strategy when using a distributional cost-effectiveness...
Source: MedPage Today Public Health - Category: American Health Source Type: news